| Announce Date | 11/25/2025 |
| EPS Normalized Actual | $0.05 (Beat by $0.41) |
| EPS GAAP Actual | $0.05 (Beat by $0.41) |
| Revenue Actual | $0.644511B |
| Revenue Surprise | Beat by $644.511M |
| Announce Date | 01/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.73 |
| EPS GAAP Estimate | $0.73 |
| Revenue Estimate | $0.8795B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jan 2030 | 0.19 | 99.84 | 0.18455 | 0.19479 | 1 |
| Jan 2029 | 3.05 | 6.22 | 2.9408 | 3.14862 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 0.05 | -1.03 | 0.644511B | -5.48% | -150.59M |
| FQ3 2025 (Jul 2025) | -0.26 | -1.15 | 0.546426B | -15.97% | -199.17M |
| FQ2 2025 (Apr 2025) | -0.58 | -1.28 | 0.594336B | -5.78% | -85.96M |
| FQ1 2025 (Jan 2025) | -1.93 | -1.93 | 0.759921B | -12.13% | 759.92M |
| FQ4 2024 (Oct 2024) | 0.0757 | 0.0757 | 0.679824B | -2.1% | 679.82M |
| FQ3 2024 (Jul 2024) | 0 | 0 | 0.633674B | -1.4% | 633.67M |
| FQ2 2024 (Apr 2024) | 0.41 | 0.41 | 0.628703B | 9.4% | 628.7M |
| FQ1 2024 (Jan 2024) | 0 | 0 | 0.852132B | 31.59% | 852.13M |
FQ4 Announce Date
01/30/2026 (Pre-Market)
Consensus EPS Estimates
0.73
Consensus Revenue Estimates
0.8795B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Oct 2027) | 0.43 | -- | 0.41854 | 0.4409 | 1 |
| FQ3 2027 (Jul 2027) | 0.22 | -- | 0.21414 | 0.22558 | 1 |
| FQ2 2027 (Apr 2027) | -0.16 | -- | -0.16406 | -0.15574 | 1 |
| FQ1 2027 (Jan 2027) | 0.12 | -- | 0.11208 | 0.12809 | 1 |
| FQ4 2026 (Oct 2026) | 0.38 | 86.84 | 0.3549 | 0.40562 | 1 |
| FQ3 2026 (Jul 2026) | -0.02 | -1200 | -0.02134863 | -0.01867918 | 1 |
| FQ2 2026 (Apr 2026) | -0.01 | -5700 | -0.01030985 | -0.00962865 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Oct 2027) | 0.67B | -- | 0.66B | 0.69B | 1 |
| FQ3 2027 (Jul 2027) | 0.54B | -- | 0.53B | 0.55B | 1 |
| FQ2 2027 (Apr 2027) | 0.54B | -- | 0.53B | 0.55B | 1 |
| FQ1 2027 (Jan 2027) | 0.66B | -- | 0.63B | 0.69B | 2 |
| FQ4 2026 (Oct 2026) | 0.59B | -9.59 | 0.56B | 0.62B | 2 |
| FQ3 2026 (Jul 2026) | 0.52B | -5.54 | 0.49B | 0.54B | 2 |
| FQ2 2026 (Apr 2026) | 0.45B | -31.75 | 0.44B | 0.46B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
4
EPS # of in-lines
2
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 1.08 | 0.05 | -1.03 | -2060% |
| FQ3 2025 (Jul 2025) | 0.89 | -0.26 | -1.15 | 442.31% |
| FQ2 2025 (Apr 2025) | 0.7 | -0.58 | -1.28 | 220.69% |
| FQ1 2025 (Jan 2025) | -1.93 | -1.93 | 100% | |
| FQ4 2024 (Oct 2024) | 0.0757 | 0.0757 | 100% | |
| FQ3 2024 (Jul 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Apr 2024) | 0.41 | 0.41 | 100% | |
| FQ1 2024 (Jan 2024) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0.8B | $0.64B | $-150.59M | -23.36% |
| FQ3 2025 (Jul 2025) | $0.75B | $0.55B | $-199.17M | -36.45% |
| FQ2 2025 (Apr 2025) | $0.68B | $0.59B | $-85.96M | -14.46% |
| FQ1 2025 (Jan 2025) | $0B | $0.76B | $759.92M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $0.68B | $679.82M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $0.63B | $633.67M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $0.63B | $628.7M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $0.85B | $852.13M | 100% |